Simplify Logo

Full-Time

Director/Sr. Director

Clinical Pharmacology & Pharmacometrics

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

501-1,000 employees

Develops RNAi-based therapies for gene targeting

Biotechnology

Compensation Overview

$220k - $300kAnnually

Senior, Expert

Madison, WI, USA + 2 more

Category
Medical, Clinical & Veterinary
Healthcare Administration & Support
Physicians & Surgeons
Required Skills
Communications
Requirements
  • PhD or equivalent in pharmacokinetics, pharmacology or pharmaceutical science
  • Track records in clinical pharmacology program leadership with 7+ years of pharmaceutical/Biotech industry experience
  • Established knowledge of drug development from Pre-INA to NDA/BLA
  • Ability to apply scientific principles to complex situations and provide effective solutions
  • Strong verbal communication and document writing skills with clarity of thinking
  • Proficiency in non-compartmental analysis of clinical PK data
Responsibilities
  • Lead the function of Clinical Pharmacology/Pharmacometrics for multiple programs in Phase 1-3 development
  • Contribute to clinical protocols design and execution; analyze data and prepare clinical study reports
  • Participate in regulatory interactions with global Health Authorities and prepare documents with submission standards
  • Maintain a current understanding of field literature for oligonucleotide therapeutics, and Model-Informed Drug Development (MIDD)
  • Provide PK/PD Modeling & Simulations to support dosing strategies for clinical programs
  • Provide leadership expertise and mentor junior team members
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals specializes in developing RNAi-based therapies using their TRiM platform, which leverages various RNA chemistries for tissue-specific targeting, enabling rapid and durable knockdown of disease-causing genes. The TRiM platform also utilizes ligand-mediated delivery, offering potential advantages such as simplified manufacturing, reduced costs, and improved safety.

Company Stage

IPO

Total Funding

$899.9M

Headquarters

Pasadena, California

Founded

2004

Growth & Insights
Headcount

6 month growth

6%

1 year growth

22%

2 year growth

58%